Your session is about to expire
← Back to Search
Aerobic Exercise for Late-Life Depression (FIT BOLD Trial)
FIT BOLD Trial Summary
This trial will investigate whether aerobic exercise training can help improve cognitive function in older adults with remitted late life depression, who are at a high risk for developing dementia.
FIT BOLD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowFIT BOLD Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.FIT BOLD Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have experienced a major depressive episode within the last 2 years.I have a reliable way to get to my appointments.I am currently receiving treatment for cancer, not including non-melanoma skin cancer.I have not had electroconvulsive therapy in the last year.I have experienced a major depressive episode after turning 55.I am not currently experiencing a major depressive episode.I can walk without pain or the need for help like canes or walkers.I haven't had a heart attack, heart surgery, or uncontrolled high blood pressure in the past year.I regularly use a device to help me walk.I am currently being treated for a heart condition or blood clots.I am 60 years old or older.I am not fluent in English.I have not been diagnosed with a neurological disease.I have a neurological condition or have had a brain injury.I am currently diagnosed with a major depressive episode.I am currently receiving treatment for depression.
- Group 1: Aerobic Exercise
- Group 2: Social Engagement
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the primary goals of this clinical evaluation?
"This clinical trial will primarily evaluate the efficacy of the intervention at reducing levels of depression. Secondary outcomes include changes in physical activity, subjective cognitive function, and intensity of physical activity - measured using wrist actigraphy data - over a period 6 months from baseline."
What is the current participant cap for this clinical trial?
"Affirmative. The information hosted on clinicaltrials.gov confirms that enrolment for this study is ongoing, having been initially posted on August 4th 2021 and most recently updated November 2nd 2022. 50 participants will be accepted across 1 medical centre."
Are there any opportunities for new participants to join this experiment?
"According to the documentation on clinicaltrials.gov, this experiment is still in need of participants and was initially advertised on August 4th 2021 with its most recent update being posted November 2nd 2022."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger